BIRC2 and plasma cell myeloma: A BIRC2/BIRC3 deletion activates non-canonical NF-κB signaling in multiple myeloma [30], whereas 11q22 amplification (containing cIAP locus) was associated with earlier onset of disease in cervical cancer [31].